feed,title,long_url,short_url
Benzinga,Analyst Sees Deteriorated Treatment Effect Of Blueprint's Much Awaited Mastocytosis Data,https://benzinga.com/analyst-ratings/analyst-color/22/08/28538959/svb-sees-deteriorated-treatment-effect-of-blueprints-much-awaited-mastocytosis-data,https://bit.ly/3wa1ttm
Benzinga,Biden Administration To Stop Purchasing COVID-19 Solutions By End Of 2022,https://benzinga.com/general/biotech/22/08/28539808/biden-administration-to-stop-purchasing-covid-19-solutions-by-end-of-2022-report,https://bit.ly/3wbA5eR
